A Conversation with Maria George Vogiatzi, MD
Adrenal disorders affect people of all ethnic groups. There are many genetic or acquired adrenal diseases, and in most cases, there is no particular ethnic group that is at adverse risk. Certain adrenal disorders, such as Cushing’s syndrome, present more frequently in women than in men. An individual that uses chronic treatment with oral or inhaled steroids can be at risk of suppressing his own adrenal function, a condition called steroid-induced adrenal insufficiency. Luckily, the adrenal function recovers once the exposure to steroids is stopped.
Several exciting research efforts are currently focused on improving the management of a genetic adrenal condition called Congenital Adrenal Hyperplasia (CAH). They include two current clinical trials of two promising investigational medications (CAHtalyst and CAHmelia), an upcoming trial of a modified- release steroid, a study of continuous hydrocortisone infusion using a pump, and last but not least, a gene therapy trial for CAH. Recently, a couple of new drugs were approved by FDA as part of the medical management of Cushing’s disease.
Team up with a group of doctors who are experts in adrenal disorders and who can provide access to the most updated therapeutic options.
Curious about the experts behind the scenes? Read more about our Patient Engagement Committee members.
You Have Questions, We Have Answers! Submit a question to our experts today!
Maria Vogiatzi, MD is an attending physician in the Division of Endocrinology at Children's Hospital of Philadelphia, leads the Adrenal and Puberty Center, and serves on the Patient Engagement Committee.
Our physician referral directory is comprised of over 6,500 members of the Society. The referral is updated daily with clinicians who are accepting new patients.
